annual CFF:
$97.57M+$156.56M(+265.37%)Summary
- As of today (September 14, 2025), LGND annual cash flow from financing activities is $97.57 million, with the most recent change of +$156.56 million (+265.37%) on December 31, 2024.
- During the last 3 years, LGND annual CFF has risen by +$235.33 million (+170.82%).
- LGND annual CFF is now -70.31% below its all-time high of $328.58 million, reached on December 31, 2018.
Performance
LGND Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$15.00M+$19.67M(+420.72%)Summary
- As of today (September 14, 2025), LGND quarterly cash flow from financing activities is $15.00 million, with the most recent change of +$19.67 million (+420.72%) on June 30, 2025.
- Over the past year, LGND quarterly CFF has increased by +$5.45 million (+57.07%).
- LGND quarterly CFF is now -97.56% below its all-time high of $613.53 million, reached on June 30, 2018.
Performance
LGND quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$86.12M+$5.45M(+6.75%)Summary
- As of today (September 14, 2025), LGND TTM cash flow from financing activities is $86.12 million, with the most recent change of +$5.45 million (+6.75%) on June 30, 2025.
- Over the past year, LGND TTM CFF has increased by +$54.81 million (+175.09%).
- LGND TTM CFF is now -87.12% below its all-time high of $668.41 million, reached on September 30, 2018.
Performance
LGND TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LGND Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +265.4% | +57.1% | +175.1% |
| 3 y3 years | +170.8% | +125.2% | +138.1% |
| 5 y5 years | +120.1% | +10000.0% | +115.0% |
LGND Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +135.3% | -72.9% | +122.1% | -11.7% | +131.2% |
| 5 y | 5-year | at high | +120.1% | -72.9% | +108.8% | -11.7% | +115.0% |
| alltime | all time | -70.3% | +120.1% | -97.6% | +104.3% | -87.1% | +111.5% |
LGND Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $15.00M(-420.7%) | $86.12M(+6.8%) |
| Mar 2025 | - | -$4.68M(-122.8%) | $80.67M(-17.3%) |
| Dec 2024 | $97.57M(-265.4%) | $20.51M(-62.9%) | $97.57M(+17.1%) |
| Sep 2024 | - | $55.29M(+479.1%) | $83.33M(+166.2%) |
| Jun 2024 | - | $9.55M(-21.9%) | $31.30M(-168.1%) |
| Mar 2024 | - | $12.22M(+95.1%) | -$46.00M(-22.0%) |
| Dec 2023 | -$59.00M(-78.6%) | $6.26M(+91.6%) | -$59.00M(-16.4%) |
| Sep 2023 | - | $3.27M(-104.8%) | -$70.56M(-38.5%) |
| Jun 2023 | - | -$67.76M(+8642.8%) | -$114.66M(+7.8%) |
| Mar 2023 | - | -$775.00K(-85.4%) | -$106.34M(-61.5%) |
| Dec 2022 | -$275.99M(+100.3%) | -$5.30M(-87.0%) | -$275.99M(+3.6%) |
| Sep 2022 | - | -$40.83M(-31.3%) | -$266.53M(+17.9%) |
| Jun 2022 | - | -$59.44M(-65.1%) | -$226.08M(+4.4%) |
| Mar 2022 | - | -$170.42M(-4192.7%) | -$216.55M(+57.2%) |
| Dec 2021 | -$137.76M(-55.6%) | $4.16M(-1181.6%) | -$137.76M(-18.7%) |
| Sep 2021 | - | -$385.00K(-99.2%) | -$169.45M(-1.9%) |
| Jun 2021 | - | -$49.91M(-45.5%) | -$172.78M(+40.6%) |
| Mar 2021 | - | -$91.64M(+232.9%) | -$122.88M(-60.4%) |
| Dec 2020 | -$310.55M(-36.0%) | -$27.53M(+642.8%) | -$310.55M(-15.3%) |
| Sep 2020 | - | -$3.71M(>+9900.0%) | -$366.71M(-36.1%) |
| Jun 2020 | - | -$5000.00(-100.0%) | -$574.32M(-6.1%) |
| Mar 2020 | - | -$279.31M(+233.7%) | -$611.90M(+26.1%) |
| Dec 2019 | -$485.17M(-247.7%) | -$83.69M(-60.4%) | -$485.17M(-35.2%) |
| Sep 2019 | - | -$211.31M(+462.1%) | -$748.56M(+56.5%) |
| Jun 2019 | - | -$37.59M(-75.4%) | -$478.33M(-376.8%) |
| Mar 2019 | - | -$152.58M(-56.0%) | $172.78M(-47.4%) |
| Dec 2018 | $328.58M(-4467.7%) | -$347.08M(-689.1%) | $328.58M(-50.8%) |
| Sep 2018 | - | $58.92M(-90.4%) | $668.41M(+9.4%) |
| Jun 2018 | - | $613.53M(>+9900.0%) | $610.90M(<-9900.0%) |
| Mar 2018 | - | $3.22M(-144.4%) | -$2.63M(-65.0%) |
| Dec 2017 | -$7.52M(-596.6%) | -$7.25M(-616.7%) | -$7.52M(+218.5%) |
| Sep 2017 | - | $1.40M(<-9900.0%) | -$2.36M(+10.5%) |
| Jun 2017 | - | -$5000.00(-99.7%) | -$2.14M(+222.3%) |
| Mar 2017 | - | -$1.67M(-20.4%) | -$663.00K(-143.8%) |
| Dec 2016 | $1.51M(-81.9%) | -$2.09M(-228.5%) | $1.51M(-70.2%) |
| Sep 2016 | - | $1.63M(+10.9%) | $5.08M(+3.4%) |
| Jun 2016 | - | $1.47M(+187.5%) | $4.91M(-39.3%) |
| Mar 2016 | - | $511.00K(-65.2%) | $8.09M(-3.2%) |
| Dec 2015 | $8.36M(-93.6%) | $1.47M(+0.7%) | $8.36M(-137.8%) |
| Sep 2015 | - | $1.46M(-68.6%) | -$22.11M(-115.9%) |
| Jun 2015 | - | $4.65M(+495.3%) | $138.75M(+5.9%) |
| Mar 2015 | - | $781.00K(-102.7%) | $131.05M(+0.8%) |
| Dec 2014 | $130.03M(-890.0%) | -$29.00M(-117.9%) | $130.03M(-16.8%) |
| Sep 2014 | - | $162.32M(-5408.0%) | $156.36M(-2052.0%) |
| Jun 2014 | - | -$3.06M(+1168.9%) | -$8.01M(+9.6%) |
| Mar 2014 | - | -$241.00K(-91.0%) | -$7.31M(-55.6%) |
| Dec 2013 | -$16.46M(-520.3%) | -$2.66M(+30.0%) | -$16.46M(+55.9%) |
| Sep 2013 | - | -$2.05M(-13.2%) | -$10.56M(+49.3%) |
| Jun 2013 | - | -$2.36M(-74.9%) | -$7.07M(+52.7%) |
| Mar 2013 | - | -$9.39M(-390.2%) | -$4.63M(-218.3%) |
| Dec 2012 | $3.92M(-86.9%) | $3.23M(+124.8%) | $3.92M(+434.2%) |
| Sep 2012 | - | $1.44M(+1654.9%) | $733.00K(-204.1%) |
| Jun 2012 | - | $82.00K(-109.8%) | -$704.00K(-116.7%) |
| Mar 2012 | - | -$840.00K(-1715.4%) | $4.21M(-86.0%) |
| Dec 2011 | $30.00M(<-9900.0%) | $52.00K(+2500.0%) | $30.00M(+0.8%) |
| Sep 2011 | - | $2000.00(-100.0%) | $29.77M(+0.1%) |
| Jun 2011 | - | $5.00M(-80.0%) | $29.73M(+20.0%) |
| Mar 2011 | - | $24.95M(<-9900.0%) | $24.78M(<-9900.0%) |
| Dec 2010 | -$159.00K(-95.7%) | -$178.00K(+334.1%) | -$159.00K(-250.0%) |
| Sep 2010 | - | -$41.00K(-178.8%) | $106.00K(+125.5%) |
| Jun 2010 | - | $52.00K(+550.0%) | $47.00K(-149.5%) |
| Mar 2010 | - | $8000.00(-90.8%) | -$95.00K(-97.4%) |
| Dec 2009 | -$3.69M | $87.00K(-187.0%) | -$3.69M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$100.00K(+11.1%) | -$3.98M(-5.5%) |
| Jun 2009 | - | -$90.00K(-97.5%) | -$4.21M(-6.6%) |
| Mar 2009 | - | -$3.58M(+1683.6%) | -$4.50M(+49.6%) |
| Dec 2008 | -$3.01M(-99.1%) | -$201.00K(-39.3%) | -$3.01M(-59.3%) |
| Sep 2008 | - | -$331.00K(-14.0%) | -$7.39M(-57.7%) |
| Jun 2008 | - | -$385.00K(-81.6%) | -$17.49M(-94.1%) |
| Mar 2008 | - | -$2.09M(-54.3%) | -$294.37M(-10.2%) |
| Dec 2007 | -$327.70M(-1084.1%) | -$4.58M(-56.1%) | -$327.70M(+12.8%) |
| Sep 2007 | - | -$10.43M(-96.2%) | -$290.42M(+3.8%) |
| Jun 2007 | - | -$277.26M(+682.7%) | -$279.81M(>+9900.0%) |
| Mar 2007 | - | -$35.42M(-208.3%) | -$2.17M(-106.5%) |
| Dec 2006 | $33.30M(<-9900.0%) | $32.70M(>+9900.0%) | $33.30M(+5621.8%) |
| Sep 2006 | - | $179.00K(-53.6%) | $582.00K(-232.6%) |
| Jun 2006 | - | $386.00K(+841.5%) | -$439.00K(-55.1%) |
| Mar 2006 | - | $41.00K(-270.8%) | -$978.00K(+386.6%) |
| Dec 2005 | -$201.00K(-102.5%) | -$24.00K(-97.1%) | -$201.00K(-8.6%) |
| Sep 2005 | - | -$842.00K(+450.3%) | -$220.00K(-107.3%) |
| Jun 2005 | - | -$153.00K(-118.7%) | $3.00M(-39.7%) |
| Mar 2005 | - | $818.00K(-2002.3%) | $4.98M(-37.1%) |
| Dec 2004 | $7.92M(-80.7%) | -$43.00K(-101.8%) | $7.92M(-37.1%) |
| Sep 2004 | - | $2.38M(+30.6%) | $12.58M(-78.5%) |
| Jun 2004 | - | $1.82M(-51.4%) | $58.49M(-4.1%) |
| Mar 2004 | - | $3.75M(-18.8%) | $61.01M(+49.0%) |
| Dec 2003 | $40.95M(-73.1%) | $4.62M(-90.4%) | $40.95M(-75.5%) |
| Sep 2003 | - | $48.29M(+1012.3%) | $167.42M(+38.3%) |
| Jun 2003 | - | $4.34M(-126.6%) | $121.08M(-9.8%) |
| Mar 2003 | - | -$16.30M(-112.4%) | $134.22M(-11.7%) |
| Dec 2002 | $152.04M(+327.1%) | $131.09M(+6594.8%) | $152.04M(+557.3%) |
| Sep 2002 | - | $1.96M(-88.8%) | $23.13M(+4.8%) |
| Jun 2002 | - | $17.48M(+1050.6%) | $22.08M(+234.7%) |
| Mar 2002 | - | $1.52M(-30.2%) | $6.59M(-81.5%) |
| Dec 2001 | $35.59M(+196.0%) | $2.18M(+141.1%) | $35.59M(+4.4%) |
| Sep 2001 | - | $903.00K(-54.8%) | $34.09M(+2.2%) |
| Jun 2001 | - | $2.00M(-93.5%) | $33.34M(-14.3%) |
| Mar 2001 | - | $30.52M(+4455.1%) | $38.91M(+223.6%) |
| Dec 2000 | $12.03M(-85.4%) | $670.00K(+335.1%) | $12.03M(-53.3%) |
| Sep 2000 | - | $154.00K(-98.0%) | $25.73M(-71.1%) |
| Jun 2000 | - | $7.57M(+108.2%) | $89.01M(+3.0%) |
| Mar 2000 | - | $3.63M(-74.7%) | $86.45M(+4.7%) |
| Dec 1999 | $82.54M(+25.4%) | $14.38M(-77.3%) | $82.54M(-28.4%) |
| Sep 1999 | - | $63.43M(+1166.3%) | $115.24M(+72.8%) |
| Jun 1999 | - | $5.01M(-1895.3%) | $66.68M(+2.1%) |
| Mar 1999 | - | -$279.00K(-100.6%) | $65.33M(-0.7%) |
| Dec 1998 | $65.81M(+80.5%) | $47.08M(+216.5%) | $65.81M(+27.7%) |
| Sep 1998 | - | $14.87M(+306.6%) | $51.54M(+38.3%) |
| Jun 1998 | - | $3.66M(+1675.7%) | $37.26M(+10.9%) |
| Mar 1998 | - | $206.00K(-99.4%) | $33.61M(-7.9%) |
| Dec 1997 | $36.47M(-18.4%) | $32.80M(+5366.7%) | $36.50M(-18.5%) |
| Sep 1997 | - | $600.00K(>+9900.0%) | $44.80M(+3.2%) |
| Jun 1997 | - | $0.00(-100.0%) | $43.40M(-0.7%) |
| Mar 1997 | - | $3.10M(-92.5%) | $43.70M(-2.2%) |
| Dec 1996 | $44.67M(+154.3%) | $41.10M(-5237.5%) | $44.70M(+1141.7%) |
| Sep 1996 | - | -$800.00K(-366.7%) | $3.60M(-18.2%) |
| Jun 1996 | - | $300.00K(-92.7%) | $4.40M(+7.3%) |
| Mar 1996 | - | $4.10M(-10.9%) | $4.10M(-82.9%) |
| Dec 1995 | $17.57M(-8.7%) | - | - |
| Mar 1995 | - | $4.60M(-1633.3%) | $24.00M(+25.0%) |
| Dec 1994 | $19.23M(+511.6%) | -$300.00K(-101.5%) | $19.20M(-1.5%) |
| Sep 1994 | - | $19.90M(<-9900.0%) | $19.50M(-4975.0%) |
| Jun 1994 | - | -$200.00K(0.0%) | -$400.00K(+100.0%) |
| Mar 1994 | - | -$200.00K | -$200.00K |
| Dec 1993 | $3.14M(-95.2%) | - | - |
| Dec 1992 | $64.91M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual CFF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly CFF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM CFF year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual cash flow from financing activities?
The current annual CFF of LGND is $97.57M
What is the all time high annual CFF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual cash flow from financing activities is $328.58M
What is Ligand Pharmaceuticals Incorporated annual CFF year-on-year change?
Over the past year, LGND annual cash flow from financing activities has changed by +$156.56M (+265.37%)
What is Ligand Pharmaceuticals Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of LGND is $15.00M
What is the all time high quarterly CFF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly cash flow from financing activities is $613.53M
What is Ligand Pharmaceuticals Incorporated quarterly CFF year-on-year change?
Over the past year, LGND quarterly cash flow from financing activities has changed by +$5.45M (+57.07%)
What is Ligand Pharmaceuticals Incorporated TTM cash flow from financing activities?
The current TTM CFF of LGND is $86.12M
What is the all time high TTM CFF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM cash flow from financing activities is $668.41M
What is Ligand Pharmaceuticals Incorporated TTM CFF year-on-year change?
Over the past year, LGND TTM cash flow from financing activities has changed by +$54.81M (+175.09%)